| Population-based mechanistic prediction of oral drug absorption M Jamei, D Turner, J Yang, S Neuhoff, S Polak, A Rostami-Hodjegan, ... The AAPS journal 11, 225-237, 2009 | 482 | 2009 |
| PBPK models for the prediction of in vivo performance of oral dosage forms ES Kostewicz, L Aarons, M Bergstrand, MB Bolger, A Galetin, O Hatley, ... European Journal of Pharmaceutical Sciences 57, 300-321, 2014 | 330 | 2014 |
| Rapid quantification of molecular diversity for selective database acquisition DB Turner, SM Tyrrell, P Willett Journal of chemical information and computer sciences 37 (1), 18-22, 1997 | 152 | 1997 |
| Similarity searching in files of three-dimensional chemical structures: evaluation of the EVA descriptor and combination of rankings using data fusion CMR Ginn, DB Turner, P Willett, AM Ferguson, TW Heritage Journal of Chemical Information and Computer Sciences 37 (1), 23-37, 1997 | 101 | 1997 |
| Evaluation of a novel infrared range vibration-based descriptor (EVA) for QSAR studies. 1. General application DB Turner, P Willett, AM Ferguson, T Heritage Journal of computer-aided molecular design 11, 409-422, 1997 | 89 | 1997 |
| Model-Based Analysis of Biopharmaceutic Experiments To Improve Mechanistic Oral Absorption Modeling: An Integrated in Vitro in Vivo Extrapolation Perspective … SM Pathak, A Ruff, ES Kostewicz, N Patel, DB Turner, M Jamei Molecular pharmaceutics 14 (12), 4305-4320, 2017 | 82 | 2017 |
| Effect of parameter variations on the effectiveness of HQSAR analyses M Seel, DB Turner, P Willett Quantitative Structure‐Activity Relationships 18 (3), 245-252, 1999 | 76 | 1999 |
| Gastrointestinal transfer: in vivo evaluation and implementation in in vitro and in silico predictive tools B Hens, J Brouwers, B Anneveld, M Corsetti, M Symillides, M Vertzoni, ... European journal of pharmaceutical sciences 63, 233-242, 2014 | 74 | 2014 |
| In Silico Modeling Approach for the Evaluation of Gastrointestinal Dissolution, Supersaturation, and Precipitation of Posaconazole B Hens, SM Pathak, A Mitra, N Patel, B Liu, S Patel, M Jamei, J Brouwers, ... Molecular pharmaceutics 14 (12), 4321-4333, 2017 | 71 | 2017 |
| Application of permeability-limited physiologically-based pharmacokinetic models: part I–digoxin pharmacokinetics incorporating P-glycoprotein-mediated efflux S Neuhoff, KR Yeo, Z Barter, M Jamei, DB Turner, A Rostami-Hodjegan Journal of pharmaceutical sciences 102 (9), 3145-3160, 2013 | 70 | 2013 |
| Application of permeability‐limited physiologically-based pharmacokinetic models: Part II-prediction of p‐glycoprotein mediated drug–drug interactions with digoxin S Neuhoff, KR Yeo, Z Barter, M Jamei, DB Turner, A Rostami‐Hodjegan Journal of pharmaceutical sciences 102 (9), 3161-3173, 2013 | 64 | 2013 |
| Development and applications of a physiologically-based model of paediatric oral drug absorption TN Johnson, JJ Bonner, GT Tucker, DB Turner, M Jamei European Journal of Pharmaceutical Sciences 115, 57-67, 2018 | 59 | 2018 |
| The EVA spectral descriptor DB Turner, P Willett European Journal of Medicinal Chemistry 35 (4), 367-375, 2000 | 57 | 2000 |
| Evaluation of a novel molecular vibration-based descriptor (EVA) for QSAR studies: 2. Model validation using a benchmark steroid dataset DB Turner, P Willett, AM Ferguson, TW Heritage Journal of computer-aided molecular design 13, 271-296, 1999 | 54 | 1999 |
| Evaluation of the EVA descriptor for QSAR studies: 3. The use of a genetic algorithm to search for models with enhanced predictive properties (EVA_GA) DB Turner, P Willett Journal of Computer-Aided Molecular Design 14, 1-21, 2000 | 52 | 2000 |
| Quantitative prediction of formulation-specific food effects and their population variability from in vitro data with the physiologically-based ADAM model: A case … N Patel, S Polak, M Jamei, A Rostami-Hodjegan, DB Turner European Journal of Pharmaceutical Sciences 57, 240-249, 2014 | 50 | 2014 |
| Application of the MechPeff model to predict passive effective intestinal permeability in the different regions of the rodent small intestine and colon D Pade, M Jamei, A Rostami‐Hodjegan, DB Turner Biopharmaceutics & drug disposition 38 (2), 94-114, 2017 | 45 | 2017 |
| Prediction of nonspecific hepatic microsomal binding from readily available physicochemical properties DB Turner, A Rostami-Hodjegan, GT Tucker, KR Yeo Drug Metab Rev 38 (Suppl 1), 162, 2006 | 43 | 2006 |
| EVA: A novel theoretical descriptor for QSAR studies TW Heritageª, AM Fergusonª, DB Turnerb, P Willettb 3D QSAR in Drug Design: Volume 2: Ligand-Protein Interactions and Molecular …, 1998 | 43 | 1998 |
| The use of ROC analysis for the qualitative prediction of human oral bioavailability from animal data A Olivares-Morales, OJD Hatley, D Turner, A Galetin, L Aarons, ... Pharmaceutical research 31, 720-730, 2014 | 36 | 2014 |
